It is a healthcare private limited company based in Kanpur, Uttar Pradesh, India, established in 2011.
2011 | Kanpur, Uttar Pradesh, India | ActiveSky Medipharma Private Limited, a active private limited company, was established on 11 April 2011 in Kanpur, Uttar Pradesh, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74120UP2011PTC044320. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Amit Narain (Director), Namrata Dwivedi (Director). Past directors included Ashutosh Bajpai, Jagdish Dwivedi Narain, Anu Passan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 117/H-2/146F-3 Pandu Nagar, Kanpur, Uttar Pradesh, 208005.
U74120UP2011PTC044320
044320
11 April 2011
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Sky Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Narain | Director | 12 Aug 2013 | Current |
| Namrata Dwivedi | Director | 19 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Sep 2012 | Past |
| Pramod Abcsdd | Managing Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 02 Sep 2012 | Past |
| Pramod Abcsdd | Whole-Time Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sky Medipharma Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 29.1% increase. The company also saw a substantial improvement in profitability, with a 369.85% increase in profit. The company's net worth Soared by an impressive increase of 21.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Sky Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sky Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sky Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Namrata Dwivedi was appointed as a Director was appointed as a Director on 19 Dec 2024 & has been associated with this company since 11 months 6 days . was documented.
Sky Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Sky Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Amit Narain was appointed as a Director was appointed as a Director on 12 Aug 2013 & has been associated with this company since 12 years 3 months . was completed.
The activity Sky Medipharma Private Limited was registered on 11 Apr 2011 with Roc Kanpur & aged 14 years 7 months as per MCA records. was completed.
The CIN of Sky Medipharma Private Limited is U74120UP2011PTC044320.
Sky Medipharma Private Limited is headquartered at 117/H-2/146F-3 Pandu Nagar, Kanpur, Uttar Pradesh, 208005.
Sky Medipharma Private Limited was incorporated on 11 April 2011.
The current directors of Sky Medipharma Private Limited are
The primary industry of Sky Medipharma Private Limited is Hospital And Medical Care.
Sky Medipharma Private Limited is unlisted.
The authorized capital of Sky Medipharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Sky Medipharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX